Patton Albertson Miller Group, LLC Novartis Ag Transaction History

Patton Albertson Miller Group, LLC

$732 Million
Q4 2024

A detailed history of Patton Albertson Miller Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Patton Albertson Miller Group, LLC holds 5,429 shares of NVS stock, worth $604,519. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,429

Previous 5,459 0.55%

Holding current value

$604,519

Previous $627,000 15.79%

% of portfolio

0.07%

Previous 0.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$96.78 - $117.18 $2,903 - $3,515	-30 Reduced 0.55%	5,429 $528,000
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $742 - $846	-7 Reduced 0.13%	5,459 $627,000
Q2 2024 Aug 02, 2024	SELL	$92.57 - $107.37 $19,902 - $23,084	-215 Reduced 3.78%	5,466 $581,000
Q1 2024 Apr 24, 2024	SELL	$95.27 - $108.47 $7,907 - $9,003	-83 Reduced 1.44%	5,681 $549,000
Q4 2023 Feb 07, 2024	SELL	$92.27 - $101.54 $9,227 - $10,154	-100 Reduced 1.71%	5,764 $581,000
Q3 2023 Oct 24, 2023	SELL	$94.73 - $105.13 $4,736 - $5,256	-50 Reduced 0.85%	5,864 $597,000
Q2 2023 Jul 13, 2023	SELL	$92.52 - $104.91 $44,409 - $50,356	-480 Reduced 7.51%	5,914 $596,000
Q1 2023 Apr 21, 2023	SELL	$80.03 - $92.81 $3,201 - $3,712	-40 Reduced 0.62%	6,394 $588,000
Q4 2022 Jan 23, 2023	SELL	$75.55 - $92.52 $36,641 - $44,872	-485 Reduced 7.01%	6,434 $0
Q3 2022 Oct 13, 2022	SELL	$74.61 - $87.26 $46,929 - $54,886	-629 Reduced 8.33%	6,919 $526,000
Q2 2022 Jul 22, 2022	SELL	$80.52 - $93.75 $185,598 - $216,093	-2,305 Reduced 23.39%	7,548 $638,000
Q1 2022 May 02, 2022	BUY	$80.11 - $90.62 $1,041 - $1,178	13 Added 0.13%	9,853 $865,000
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $209,212 - $231,341	-2,625 Reduced 21.06%	9,840 $861,000
Q3 2021 Oct 27, 2021	SELL	$81.78 - $95.14 $22,489 - $26,163	-275 Reduced 2.16%	12,465 $1.02 Million
Q2 2021 Jul 29, 2021	SELL	$85.24 - $94.15 $90,524 - $99,987	-1,062 Reduced 7.69%	12,740 $1.16 Million
Q1 2021 Apr 21, 2021	BUY	$83.5 - $98.47 $2,087 - $2,461	25 Added 0.18%	13,802 $1.18 Million
Q4 2020 Feb 25, 2021	SELL	$78.07 - $94.43 $93,059 - $112,560	-1,192 Reduced 7.96%	13,777 $1.26 Million
Q3 2020 Nov 03, 2020	SELL	$82.14 - $91.0 $111,546 - $123,578	-1,358 Reduced 8.32%	14,969 $1.3 Million
Q1 2020 May 22, 2020	SELL	$70.67 - $99.01 $26,501 - $37,128	-375 Reduced 2.25%	16,327 $1.35 Million
Q4 2019 Feb 06, 2020	SELL	$84.35 - $95.37 $12,652 - $14,305	-150 Reduced 0.89%	16,702 $1.58 Million
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $49,442 - $54,482	-578 Reduced 3.32%	16,852 $1.46 Million
Q2 2019 Aug 12, 2019	BUY	$75.4 - $92.8 $1.12 Million - $1.38 Million	14,920 Added 594.42%	17,430 $1.58 Million
Q3 2018 Oct 25, 2018	BUY	$66.94 - $77.43 $168,019 - $194,349	2,510 New	2,510 $211,000
Q1 2018 May 01, 2018	SELL	$70.39 - $84.15 $350,542 - $419,067	-4,980 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$72.33 - $77.64 $10,415 - $11,180	-144 Reduced 2.81%	4,980 $418,000
Q3 2017 Oct 06, 2017	BUY	$74.14 - $77.27 $379,893 - $395,931	5,124	5,124 $439,000

Others Institutions Holding NVS

# of Institutions

1,479

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $240B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Albertson Miller Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patton Albertson Miller Group, LLC with notifications on news.

Account

Patton Albertson Miller Group, LLC Novartis Ag Transaction History